加齢黄斑変性（AMD）の世界市場：市場規模・現状・予測

• 英文タイトル：Global Age Related Macular Degeneration (AMD) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04093 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、加齢黄斑変性（AMD）の世界市場について調査・分析し、加齢黄斑変性（AMD）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ウエットAMD、ドライAMD）、用途別（男性、女性）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の加齢黄斑変性（AMD）市場動向 ・主要企業別マーケットシェア ・加齢黄斑変性（AMD）の種類別市場規模2014-2019 （ウエットAMD、ドライAMD） ・加齢黄斑変性（AMD）の用途別市場規模2014-2019 （男性、女性） ・加齢黄斑変性（AMD）の北米市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性（AMD）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性（AMD）の中国市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性（AMD）の日本国内市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性（AMD）の東南アジア市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性（AMD）のインド市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性（AMD）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bayer、F. HoffmannLa Roche、Regeneron、Novartis、Valeant、Pfizer） ・加齢黄斑変性（AMD）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.In 2018, the global Age Related Macular Degeneration (AMD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Age Related Macular Degeneration (AMD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Age Related Macular Degeneration (AMD) development in United States, Europe and China.

The key players covered in this study
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
…

Market segment by Type, the product can be split into
Wet AMD
Dry AMD

Market segment by Application, split into
Men
Woman

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Age Related Macular Degeneration (AMD) status, future forecast, growth opportunity, key market and key players.
To present the Age Related Macular Degeneration (AMD) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Age Related Macular Degeneration (AMD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age Related Macular Degeneration (AMD) Market Share by Application (2014-2025)
1.5.2 Men
1.5.3 Woman
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Age Related Macular Degeneration (AMD) Market Size
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Regions
2.2.1 Age Related Macular Degeneration (AMD) Market Size by Regions (2014-2025)
2.2.2 Age Related Macular Degeneration (AMD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Age Related Macular Degeneration (AMD) Market Size by Manufacturers
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.2 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.3 Key Players Age Related Macular Degeneration (AMD) Product/Solution/Service
3.4 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019)
4.2 Global Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019)

5 United States
5.1 United States Age Related Macular Degeneration (AMD) Market Size (2014-2019)
5.2 Age Related Macular Degeneration (AMD) Key Players in United States
5.3 United States Age Related Macular Degeneration (AMD) Market Size by Type
5.4 United States Age Related Macular Degeneration (AMD) Market Size by Application

6 Europe
6.1 Europe Age Related Macular Degeneration (AMD) Market Size (2014-2019)
6.2 Age Related Macular Degeneration (AMD) Key Players in Europe
6.3 Europe Age Related Macular Degeneration (AMD) Market Size by Type
6.4 Europe Age Related Macular Degeneration (AMD) Market Size by Application

7 China
7.1 China Age Related Macular Degeneration (AMD) Market Size (2014-2019)
7.2 Age Related Macular Degeneration (AMD) Key Players in China
7.3 China Age Related Macular Degeneration (AMD) Market Size by Type
7.4 China Age Related Macular Degeneration (AMD) Market Size by Application

8 Japan
8.1 Japan Age Related Macular Degeneration (AMD) Market Size (2014-2019)
8.2 Age Related Macular Degeneration (AMD) Key Players in Japan
8.3 Japan Age Related Macular Degeneration (AMD) Market Size by Type
8.4 Japan Age Related Macular Degeneration (AMD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Age Related Macular Degeneration (AMD) Market Size (2014-2019)
9.2 Age Related Macular Degeneration (AMD) Key Players in Southeast Asia
9.3 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type
9.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application

10 India
10.1 India Age Related Macular Degeneration (AMD) Market Size (2014-2019)
10.2 Age Related Macular Degeneration (AMD) Key Players in India
10.3 India Age Related Macular Degeneration (AMD) Market Size by Type
10.4 India Age Related Macular Degeneration (AMD) Market Size by Application

11 Central & South America
11.1 Central & South America Age Related Macular Degeneration (AMD) Market Size (2014-2019)
11.2 Age Related Macular Degeneration (AMD) Key Players in Central & South America
11.3 Central & South America Age Related Macular Degeneration (AMD) Market Size by Type
11.4 Central & South America Age Related Macular Degeneration (AMD) Market Size by Application

12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Age Related Macular Degeneration (AMD) Introduction
12.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 F. HoffmannLa Roche
12.2.1 F. HoffmannLa Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Age Related Macular Degeneration (AMD) Introduction
12.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.2.5 F. HoffmannLa Roche Recent Development
12.3 Regeneron
12.3.1 Regeneron Company Details
12.3.2 Company Description and Business Overview
12.3.3 Age Related Macular Degeneration (AMD) Introduction
12.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.3.5 Regeneron Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Age Related Macular Degeneration (AMD) Introduction
12.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Valeant
12.5.1 Valeant Company Details
12.5.2 Company Description and Business Overview
12.5.3 Age Related Macular Degeneration (AMD) Introduction
12.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.5.5 Valeant Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Age Related Macular Degeneration (AMD) Introduction
12.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.6.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Age Related Macular Degeneration (AMD) Key Market Segments
Table Key Players Age Related Macular Degeneration (AMD) Covered
Table Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type 2014-2025
Figure Wet AMD Figures
Table Key Players of Wet AMD
Figure Dry AMD Figures
Table Key Players of Dry AMD
Table Global Age Related Macular Degeneration (AMD) Market Size Growth by Application 2014-2025 (Million US$)
Figure Men Case Studies
Figure Woman Case Studies
Figure Age Related Macular Degeneration (AMD) Report Years Considered
Table Global Age Related Macular Degeneration (AMD) Market Size 2014-2025 (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions 2014-2025 (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions 2014-2019 (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Share by Regions 2014-2019
Figure Global Age Related Macular Degeneration (AMD) Market Share by Regions 2014-2019
Figure Global Age Related Macular Degeneration (AMD) Market Share by Regions 2019
Table Market Top Trends
Table Global Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Share by Manufacturers (2014-2019)
Figure Global Age Related Macular Degeneration (AMD) Market Share by Manufacturers in 2018
Table Global Age Related Macular Degeneration (AMD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Age Related Macular Degeneration (AMD) Product/Solution/Service
Table Date of Enter into Age Related Macular Degeneration (AMD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size Share by Type (2014-2019)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2014-2019)
Table Global Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size Share by Application (2014-2019)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2014-2019)
Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2018
Figure United States Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table United States Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table United States Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table United States Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table United States Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table United States Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table United States Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Europe Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Europe Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Europe Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Europe Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Europe Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Europe Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Europe Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure China Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table China Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table China Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table China Age Related Macular Degeneration (AMD) Market Size by Type (2014-20189) (Million US$)
Table China Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table China Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table China Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Japan Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Japan Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Japan Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Japan Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Japan Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Japan Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Japan Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure India Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table India Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table India Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table India Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table India Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table India Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table India Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Central & South America Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Central & South America Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Central & South America Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Table Bayer Company Details
Table Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019) (Million US$)
Figure Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Bayer Recent Development
Table F. HoffmannLa Roche Company Details
Table F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2014-2019)
Table F. HoffmannLa Roche Recent Development
Table Regeneron Company Details
Table Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Regeneron Recent Development
Table Novartis Company Details
Table Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Novartis Recent Development
Table Valeant Company Details
Table Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Valeant Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Pfizer Recent Development
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions (Million US$) 2019-2025
Figure Global Age Related Macular Degeneration (AMD) Market Size Share by Regions (2019-2025)
Figure Global Age Related Macular Degeneration (AMD) Market Size Share by Regions in 2025
Figure United States Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure China Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure India Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Table Global Age Related Macular Degeneration (AMD) Market Size by Product (2019-2025) (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Product (2019-2025)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Product in 2025
Table Global Age Related Macular Degeneration (AMD) Market Size by Application (2019-2025) (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Application (2019-2025)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---